Publications by authors named "Nanette Silverberg"
Background: International Dermatology Outcome Measures (IDEOM) is a non-profit organization whose mission is to improve the availability of evidence-based, consensus-driven outcome measures for dermatological diseases. IDEOM facilitates collaboration between stakeholders from various backgrounds, including researchers, patients, physicians, and industry representatives, to develop objective benchmark metrics that enable better treatment and management of dermatologic conditions.
Summary: The 2023 IDEOM Annual Meeting was held June 23-24, 2023.
Article Synopsis
- The IDEOM Vitiligo Workgroup aims to create a standardized approach for reporting the severity of vitiligo, as current methods are inconsistent and lack uniformity.
- A literature review identified 50 clinical trials focusing on topical treatments for vitiligo, revealing various grading systems for measuring repigmentation and quality of life.
- The study suggests employing metrics like body surface area scoring and the Vitiligo Area Scoring Index to improve data collection, while also considering new factors like treatment burden and cost-effectiveness.
Atopic dermatitis (AD) is a multi-system inflammatory skin disorder with early onset in the skin. It is well known that Black and Hispanic children in the United States experience specific barriers in regards to accessing care for AD, including greater severity on presentation and more need for care including increased usage of emergency services. Understanding these social determinants is vital if social change is to be made and if policies are to be constructed to create enduring reductions in disparity in a meaningful way that can potentially level disease severity and access to care for all segments of the family.
View Article and Find Full Text PDFAtopic dermatitis (AD) begins in early childhood in the majority of children. Addressing AD in small children includes recognition of the early presentations of disease in all skin types, triggers, comorbidities, and therapeutics. These include risk of medication absorption, more xerosis, infections, and creating management plans that are acceptable to parents/caregivers, while offering safety.
View Article and Find Full Text PDFArticle Synopsis
- * The review introduces a mnemonic, VINDICATE-P, to categorize the various comorbidities linked with AD, including cardiovascular, infectious, and neurological conditions, among others.
- * Understanding these comorbidities can differ based on the patient's age, and further research is necessary to explore how they develop and how best to screen for them in AD patients.
Atopic dermatitis is an inflammatory skin condition that largely affects children. Atopic dermatitis has the potential to persist into adulthood and continue to negatively affect the lives of those who are burdened with it. This condition can have a large impact on the quality of life of those who are affected from birth through senescence.
View Article and Find Full Text PDFArticle Synopsis
- There is a need for evidence-based treatment guidelines for vitiligo specifically tailored for pediatric, adolescent, and young adult patients in the US.
- A literature review involving consensus-building among experts led to the formation of 42 recommendations regarding the diagnosis and treatment of vitiligo in young patients.
- Key findings included strong recommendations for treatments such as topical calcineurin inhibitors and topical corticosteroids, with specific guidance on duration and patient age considerations for effective management.
Article Synopsis
- The study examined the effectiveness and safety of berdazimer gel, a topical antiviral treatment, in controlling molluscum contagiosum (MC) infections in patients with and without atopic dermatitis (AD).
- It involved a combined analysis of three Phase 3 clinical trials, where patients applied berdazimer or a placebo daily for 12 weeks, measuring the complete clearance of lesions as the primary outcome.
- Results indicated higher clearance rates for berdazimer compared to the placebo in both subgroups, though some application-site adverse effects were noted, particularly in patients with concurrent AD.
Background: No guidelines exist for pediatric vitiligo.
Objective: To identify practice patterns of pediatric dermatologists treating vitiligo.
Methods: A PeDRA survey was completed online by 56 pediatric dermatologists.
Background: The International Dermatology Outcome Measures (IDEOM) is a non-profit organization dedicated to the advancement of evidence-based, consensus-driven outcome measures in dermatological diseases. Researchers and stakeholders from various backgrounds collaborate to develop these objective benchmark metrics to further advance treatment and management of dermatological conditions.
Summary: The 2022 IDEOM Annual Meeting was held on June 17-18, 2022.
Article Synopsis
- After smallpox was eradicated, there have been more frequent small outbreaks of monkeypox (mpox), especially in Africa.
- The rapid spread of mpox in 2022 raises concerns of a potential second zoonotic pandemic in the 21st century.
- This article serves as a guide for dermatologists, covering the history, symptoms, complications, diagnosis, transmission, infection control, vaccination, and treatment options for mpox.
Article Synopsis
- Acne keloidalis nuchae (AKN) is an inflammatory skin disorder mainly affecting people of color, causing keloidal and acne-like lesions on the back of the scalp.
- A study analyzed the readability of online patient education materials (PEMs) for AKN using six different readability metrics, revealing that most content was written at a level suitable for 10th to 13th-grade students.
- The findings indicate a need for more accessible and easy-to-read educational resources about AKN for patients, as much of the current information is above the recommended readability level.
The COVID-19 pandemic required a rapid expansion of teledermatology services. Analyze demographic shifts in a pediatric dermatology practice session with children of color. A retrospective chart review of pediatric dermatology patients seen in the 4 practice weeks preceding the New York COVID-19 lockdown and comparable teledermatology visits during the COVID-19 pandemic lockdown.
View Article and Find Full Text PDFBackground: International Dermatology Outcome Measures (IDEOM) is a non-profit organization founded in 2013. It is composed of researchers and stakeholders who work to develop evidenced-based outcome measures to enhance research and treatment recommendations of dermatologic diseases.
Summary: The 2021 IDEOM Virtual Annual Meeting occurred from November 19-20, 2021.
Background: Pediatric lichen planus (LP) is a relatively uncommon condition, with increased presentation in children with darkly pigmented skin.
Objective: To understand the small subset of children with lichen planus (LP) manifesting as lichen planus pigmentosus (LPP), a form with thin plaques and extensive hyperpigmentation, generally in the absence of signs of inflammation Methods: This article is a systematic review of the English language literature for cases of lichen planus pigmentosus (LPP) in children.
Results: Twenty-one cases were identified including 2 that were linear, 3 inverse types, 1 palmoplantar.